STAT3 and graft versus host disease: Stat3 inactivation in T cells enhanced PD-L1/PD-1–mediated inhibition of metabolic pathways in alloreactive T cells, thus interfering with metabolic reprogramming and leading to T cell dysfunction specifically in GVHD target organs (Figure 1).